Cancer-Myelofibrosis and Essential Thrombocythemia-MOST

Title   Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Description   The MOST study is an observational research study for adults 18 and over who have been diagnosed with myelofibrosis or essential thrombocythemia. The study will be conducted at about 250 sites in the U.S., and will recruit about 500 adults with myelofibrosis and 1,000 with essential thrombocythemia. For additional information visit ClinicalTrials.gov
NCT Number   02953704
Start Date   01/17/2017
Status Follow up; closed to enrollment
Principal Name   Kerry Pulver, MD
Contact Name   Olga Bittner, MHS, CCRC
Phone   208-367-7954